Technology
Health
Biotechnology

Homology Medicines

$25.76
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.59 (-9.14%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell FIXX and other stocks, options, ETFs, and crypto commission-free!

About

Homology Medicines, Inc. operates as a technology platform to design and develop treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Read More The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA.

Employees
124
Headquarters
Bedford, Massachusetts
Founded
2015
Market Cap
962.36M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
151.50K
High Today
$28.20
Low Today
$25.70
Open Price
$28.20
Volume
60.08K
52 Week High
$31.80
52 Week Low
$15.07

Collections

Technology
Health
Biotechnology
Therapy
2018 IPO
US
North America

News

Seeking AlphaMar 12

Homology Medicines misses by $0.07, revenue in-line - Homology Medicines, Inc. (NASDAQ:FIXX)

26

Earnings

-$0.51
-$0.49
-$0.47
-$0.45
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.45 per share
Actual
-$0.51 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.